Catalyst Wire Dossier Catalyst Wire Dossier

Engineered Lactobacillus reuteri topical formulation with zinc sulfate-tannic acid MPN coating

Lactobacillus reuteri topical live biotherapeutic with zinc sulfate-tannic acid MPN coating · Shenzhen People's Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Engineered Lactobacillus reuteri topical formulation with zinc sulfate-tannic acid MPN coating, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Topical Application of Engineered Lactobacillus Reuteri With a Zinc Sulfate-Tannic Acid MPN Coating for Acne [Phase 2]

See pricing